LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026)
LivaNova's (LIVN) quarterly Non-Current Deferred Tax Liability came in at $9.3 million in Q2 2026, down 18.28% year-over-year from $11.4 million in Q2 2025, and up 36.67% quarter-over-quarter from $6.8 million in Q1 2026.
Analysis
LivaNova (LIVN) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends
LivaNova has disclosed Non-Current Deferred Tax Liability across 12 years of filings, most recently posting $9.3 million for Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability fell 18.28% year-over-year to $9.3 million; the TTM figure through Jun 2026 stood at $9.3 million (down 18.28% YoY), while the FY2025 annual figure was $9.6 million, down 85.25% from the prior year.
- Non-Current Deferred Tax Liability came in at $9.3 million for Q2 2026 at LivaNova, up from $6.8 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $89.2 million in Q4 2022 to a low of $6.5 million in Q3 2022.
- Average Non-Current Deferred Tax Liability over 5 years is $19.9 million, with a median of $10.0 million recorded in 2023.
- Year-over-year, Non-Current Deferred Tax Liability jumped 1054.62% in 2022 and slumped 85.25% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $89.2 million in 2022, then sank by 30.34% to $62.2 million in 2023, then advanced by 4.62% to $65.0 million in 2024, then tumbled by 85.25% to $9.6 million in 2025, then dropped by 2.92% to $9.3 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $9.3 million in Q2 2026, $6.8 million in Q1 2026, and $9.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.31 Mn |
| Mar 31, 2026 | 6.81 Mn |
| Dec 31, 2025 | 9.59 Mn |
| Sep 30, 2025 | 10.10 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 65.03 Mn |
| Sep 30, 2024 | 11.84 Mn |
| Jun 30, 2024 | 10.84 Mn |
| Mar 31, 2024 | 10.97 Mn |
| Dec 31, 2023 | 62.16 Mn |
| Sep 30, 2023 | 9.93 Mn |
| Jun 30, 2023 | 8.92 Mn |
| Mar 31, 2023 | 8.63 Mn |
| Dec 31, 2022 | 89.23 Mn |
| Sep 30, 2022 | 6.53 Mn |
| Jun 30, 2022 | 7.66 Mn |
| Mar 31, 2022 | 7.88 Mn |
| Dec 31, 2021 | 7.73 Mn |
| Sep 30, 2021 | 8.31 Mn |